Tokyo, Aug. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058784) titled 'Impact of tirzepatide on FIB-4 in patients with type 2 diabetes' on Aug. 15.
Study Type:
Observational
Primary Sponsor:
Institute - Edogawa Hospital
Condition:
Condition - type 2 diabete
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To observe changes in FIB-4 in patients with type 2 diabetes treated with tirzepatide
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with type 2 diabetes who were administered tirzepatide
Key exclusion crit...